
Y-mAbs Therapeutics, Inc.
Description: Y-mAbs Therapeutics is a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody-based therapeutic products for the treatment cancer in the United States. The company has a license and research collaboration agreement with Memorial Sloan Kettering Cancer Center.
Industry: Biotechnology
Founded Year : 2015
Headquarter : New York, NY, USA
Website: http://www.ymabs.com
Phone: 646-885-8505
Theravance Biopharma, Inc.
Description: Theravance Biopharma, Inc., a diversified biopharmaceutical company, discovers, develops, and commercializes organ-selective medicines.
Industry: Biotechnology
Founded Year : 2013
Headquarter : George Town, the Cayman Islands, UK
Website: http://www.theravance.com
Phone: 650-808-6000
Orchard Therapeutics plc
Description: Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company’s gene therapy approach seeks to transform a patient’s hematopoietic stem cells into a gene-modified drug product to treat the patient’s disease through a single administration. The company was formerly known as Orchard Rx Limited.
Industry: Biotechnology
Founded Year : 2015
Headquarter : London, United Kingdom
Website: http://www.orchard-tx.com
Phone: 44 20 3384 6700
Wave Life Sciences Ltd.
Description: Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces of novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It focuses on proprietary programs in neurology in the central nervous system and neuromuscular system. The company has a research, license, and option agreement with Pfizer Inc. and Takeda Pharmaceutical Company Limited for the research, development, and commercialization.
Industry: Biotechnology
Founded Year : 2012
Headquarter : Singapore
Website: http://www.wavelifesciences.com
Phone: 65 6236 3388
No comment yet, add your voice below!